technology-news

New nanoparticle vaccine could help protect against flu and other viruses

Washington, Oct 6 : MIT engineers have developed a new type of nanoparticle that protects the vaccine long enough to generate a strong immune response - not only in the lungs, but also in mucosal surfaces far from the vaccination site, such as the gastrointestinal and reproductive tracts.


Such vaccines could help protect against influenza and other respiratory viruses, or prevent sexually transmitted diseases such as HIV, herpes simplex virus and human papilloma virus, Darrell Irvine, an MIT professor of materials science and engineering and biological engineering and the leader of the research team, said.

He is also exploring use of the particles to deliver cancer vaccines.

"This is a good example of a project where the same technology can be applied in cancer and in infectious disease. It's a platform technology to deliver a vaccine of interest," Irvine, who is a member of MIT's Koch Institute for Integrative Cancer Research and the Ragon Institute of Massachusetts General Hospital, MIT and Harvard University, said.

Only a handful of mucosal vaccines have been approved for human use; the best-known example is the Sabin polio vaccine, which is given orally and absorbed in the digestive tract. There is also a flu vaccine delivered by nasal spray, and mucosal vaccines against cholera, rotavirus and typhoid fever.

To create better ways of delivering such vaccines, Irvine and his colleagues built upon a nanoparticle they developed two years ago.

The protein fragments that make up the vaccine are encased in a sphere made of several layers of lipids that are chemically "stapled" to one another, making the particles more durable inside the body.

This allows the particles to resist disintegration once they reach the lungs.

With this sturdier packaging, the protein vaccine remains in the lungs long enough for immune cells lining the surface of the lungs to grab them and deliver them to T cells.

Activating T cells is a critical step for the immune system to form a memory of the vaccine particles so it will be primed to respond again during an infection.

The research is published in the journal Science Translational Medicine.

--ANI (Posted on 06-10-2013)

technology-news headlines

New groundbreaking technique may help cure diseases by 'editing' DNA

Ancient Antarctica was as warm as today's California coast

Domesticated chili pepper originated in Central-east Mexico

Neanderthals carried more copies of potentially detrimental mutations

'Upside-down planet' reveals new method for studying binary star systems

Learn why homo sapiens survived when others could not

New material prevents plastic from ageing

Know if you are an app addict

Animals with bigger brain size more intelligent

Now, a detector to distinguish 'sour' oil from 'sweet'

UV lamp of the future is here

Shrimp-inspired material to make airplanes stronger

Quick Links: Goa | Munnar | Pondicherry | Free Yearly Horoscope '2014

Comments

Your e-mail:


Your Full Name:


Type verification image:
verification image, type it in the box

Message:

Back to Top